Login
From:
www.gsk.com
(Uncensored)
subscribe
GSK provides update on DREAMM-3 phase III trial for Blenrep in relapsed/refractory multiple myeloma | GSK
https://www.gsk.com/en-gb/media/press-releases/gsk-provides-update-on-dreamm-3-phase-iii-trial-for-blenrep/
links
backlinks
Roast topics
Find topics
Find it!
DREAMM-3 did not meet its primary endpoint of progression-free survival (PFS)
